TrialPloS one2016

Drug-Based Lead Discovery: The Novel Ablative Antiretroviral Profile of Deferiprone in HIV-1-Infected Cells and in HIV-Infected Treatment-Naive Subjects of a Double-Blind, Placebo-Controlled, Randomized Exploratory Trial.

Deepti Saxena et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.